Your prediction
Pros and Cons of Nymox Pharmaceutical Corp. in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nymox Pharmaceutical Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nymox Pharmaceutical Corp. | - | - | - | - | - | - | - |
| Enwave Corporation | 2.330% | 3.125% | -8.333% | -49.231% | -44.068% | -27.072% | -78.778% |
| Aurinia Pharmaceuticals Inc. | -1.010% | -4.895% | -8.333% | 29.664% | -1.188% | 53.165% | 3.539% |
| Spectral Medical Inc | 1.800% | 0.000% | 4.938% | 26.866% | 6.918% | 282.883% | 282.883% |
Comments
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat

